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Abstract: Cardiomyocytes from human induced pluripotent stem cells (hiPSC-CMs) are the
most promising human source with preserved genetic background of healthy individuals or
patients. This study aimed to establish a systematic procedure for exploring development of
hiPSC-CM functional output to predict genetic cardiomyopathy outcomes and identify molecular
targets for therapy. Biomimetic substrates with microtopography and physiological stiffness can
overcome the immaturity of hiPSC-CM function. We have developed a custom-made apparatus
for simultaneous optical measurements of hiPSC-CM action potential and calcium transients to
correlate these parameters at specific time points (day 60, 75 and 90 post differentiation) and
under inotropic interventions. In later-stages, single hiPSC-CMs revealed prolonged action
potential duration, increased calcium transient amplitude and shorter duration that closely
resembled those of human adult cardiomyocytes from fresh ventricular tissue of patients. Thus,
the major contribution of sarcoplasmic reticulum and positive inotropic response to β-adrenergic
stimulation are time-dependent events underlying excitation contraction coupling (ECC) maturation
of hiPSC-CM; biomimetic substrates can promote calcium-handling regulation towards adult-like
kinetics. Simultaneous optical recordings of long-term cultured hiPSC-CMs on biomimetic substrates
favor high-throughput electrophysiological analysis aimed at testing (mechanistic hypothesis on)
disease progression and pharmacological interventions in patient-derived hiPSC-CMs.
Keywords: human induced pluripotent stem cells; cardiomyocytes; fluorescence; maturation; action
potential; calcium handling; hydrogels; long-term culture
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1. Introduction
Cardiomyocytes generated from human inducible pluripotent stem cells (hiPSCs) have become a
powerful tool for the basic-science community dedicated to heart regeneration, high-throughput drug
screening, cardiac genetics and disease modelling.
For example, the breakthrough of reprogramming somatic cells from patients into hiPSCs has
opened the possibility to characterize specific genotype/phenotypes for both the patient and their
progeny. Thus hiPSC-derived cardiomyocytes (hiPSC-CMs) can serve as a unique platform for
unveiling novel molecular targets of mechanisms underlying inherited cardiomyopathies. However,
since the inception of hiPSC-CMs [1], a major focus has been to produce cells that mirror mechanisms
found in end-stage human samples or animal models. Only a few studies have described the time
course of disease pathophysiology and/or novel mechanisms for potential therapeutic strategies [2]. It is
widely accepted that post-differentiated hiPSC-CMs are immature in both structure and function [3].
“Immaturity” comprises a wide spectrum of fetal-type features, such as automaticity (spontaneous
contraction), gene expression patterns [4] including ion channels [5], and electrophysiological signals
and contractile properties at whole cell [6] and myofibril level [7,8]. Using current approaches,
hiPSC-CMs display developmental hallmarks clearly discernable from adult cardiomyocytes isolated
from fresh cardiac tissue, thus providing a useful model to study the progression of disorders that
reflect cardiac diseases at early-stage. Therefore, much more work is still needed to categorize how the
functional properties of hiPSC-CMs change over time in culture to avoid misleading conclusions for
normal and disease phenotypes.
There is a significant need to standardize methods and techniques so that results from different
laboratories are sufficiently comparable in terms of the developmental stage of hiPSC-CMs. Many
strategies have emerged to improve hiPSC-CM structure/function maturation [3]. Among these,
we previously reported that hiPSC-CMs benefit from long-term culture on micropatterned surfaces.
In later-stages (80–100 days post differentiation), healthy hiPSC-CMs exhibited a dramatic increase
of the cell aspect ratio and myofibril alignment, with evidence of caveolae or emerging transverse
(T) tubules and expression of sarcomere protein isoforms that are generally not detected at earlier
post-differentiation time points [7,9].
In earlier times post-differentiation hiPSC-CMs exhibit spontaneous contractile activity due to
the absence or very low expression of the inward-rectifier potassium channels (IK1) that stabilizes the
membrane potential and the presence of the pacemaker funny current (If) [10]. T-tubules have been
rarely described [11] and the sarcoplasmic reticulum (SR) is still poorly developed. In this scenario,
sarcolemma calcium entry is the main source for contraction and the sodium calcium exchanger (NCX)
is mainly responsible for intracellular calcium removal [12]. Consequently, calcium handling kinetics
are slower in hiPSC-CMs compared to adult cardiomyocytes [13].
Simultaneous optical recordings of action potential and calcium transients were previously
reported from cell monolayers [14] or using genetically encoded reporters [15] at undefined maturation
stages. In this work, we present a systematic functional characterization of action potential and
calcium handling maturation using a dual optical method at specific time points in long term
hiPSC-cardiomyocytes on hydrogel-based micropatterned substrates. Hydrogel-based substrates are
easy to handle and to shape with nanoscale topographies using soft lithography techniques. Their
stiffness can be tuned to mimic the native cardiac extracellular matrix. A simultaneous optical recording
approach of action potential and calcium transient is presented here, to correlate these two parameters
and describe developmental changes of later-stages (days 60–75–90) in the development of individual
hiPSC-CM excitation contraction coupling (ECC).
We report that only in later-stages do hiPSC-CMs respond to field stimulation at various pacing
frequencies and to inotropic agents, likely resembling calcium handling features of human adult
cardiomyocytes [13]. This approach can be applied to investigate time-dependent events of more
mature hiPSC-CMs and modelling early (vs. late) morpho/functional cardiomyocyte changes associated
with inherited cardiomyopathies. This approach may allow the identification of molecular targets for
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the development of novel “disease”-specific, or even “disease stage”-specific, therapeutic approaches,
and potentially prevent the pathogenesis of cardiomyopathies before the clinical manifestation [16].
2. Results
2.1. Simultaneous Recordings of Action Potential and Calcium Transient from Single hiPSC-Cardiomyocytes
Human iPSC were differentiated into cardiomyocytes (hiPSC-CMs) using a monolayer-directed
differentiation protocol as previously described [17]. Briefly, a monoloayer with about 70% of confluency
of hiPSC colonies was exposed to the medium A (day 0) for two days to initiate the differentiation
process. Spontaneous beating monolayers are visible in about 8–10 days after cardiac induction and
employed for experiments at three “later-stages” time points: day 60, 75 and 90 (Figure 1A). At day 20
after differentiation, beating monolayers were selected and digested into single cells and plated at a
cell density of 20,000 cell/cm2 onto fibronectin-coated custom-made polyethylene glycol-diacrylate
(PEG-DA) hydrogel-based surfaces with a microstructured topography. The geometry of this biomimetic
substrate is reported in Figure 1B, presenting an array of parallel micro-grooves with 0.6 µm width,
1.5 µm height and 1.4 µm distance between lines. Of note, the stiffness (Young modulus) of the
hydrogel-based surfaces was in the order of 100 kPa, less compared to our previous reports, which was
6.7 MPa [7] and was chosen in order to more closely mimic physiological conditions of the human cardiac
extracellular matrix [18]. In order to perform a systematic functional characterization, we developed a
custom-made experimental setup based on an epifluorescence microscope to simultaneously record
action potentials and calcium transients using fluorescent indicators (FluoVolt and Cal630, respectively,
Figure 1C, Supplementary Video S1).
2.2. Action Potential and Calcium Transient of Human iPSC-Versus Adult Cardiomyocytes
At later stages of maturation, single rod-shaped hiPSC-CMs are responsive to electrical field
stimulation at various pacing rates. Action potentials (AP) was measured by acquiring the
voltage-sensitive fluorescent dye (Fluovolt) signal at day (d) 75 and 90 (Figure 2A). At day 75,
AP duration (APD) did not show a significant rate adaptation (APD50 at 1 and 2 Hz were comparable).
At d90, instead, APD50 was shortened at 2 Hz compared to 1 Hz, highlighting that mature hiPSC-CMs
acquired a typical rate-dependent APD adaptation (p < 0.01, Figure 2A). Moreover, at day 90 APD50 at
1 Hz was longer, compared to that recorded at day 75 (p < 0.01). Simultaneously, calcium transients
were measured at each time point (Figure 2B). At both 1 and 2 Hz, the kinetics of calcium rise (time to
peak, TTP) and decay (ratio between TTP and time to 50% of CaT decay, RT50) became more rapid with
maturation (Figure 2C) (p < 0.01) (Video S2 hiPSC-CMs no stimulation, Video S3 1 Hz, Video S4 2 Hz).
Similarly, calcium transient amplitude was similar at day 60 and 75, but it increased by 50% at d90
(p < 0.01 vs. d60, Figure 2C). This behavior closely matches the features of human adult cardiomyocytes
(hAdult-CMs, Figure 2D). When APD50 was plotted against calcium transient parameters recorded
from individual cells at day 90, Pearson’s correlation coefficient (r2) estimated from the linear fitting
displayed no correlation between APD50 and CaT amplitude. However, there was positive correlation
between APD50 and calcium transient RT50. This suggests that cardiomyocytes, which show longer
APD, also have a longer calcium transient duration (Figure 3A). The same correlation was found
in adult ventricular cardiomyocytes from non-failing non-hypertrophic patients, in which AP and
calcium transients were simultaneously measured with standard techniques (Figure 3B).
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Figure 1. Experimental procedure. Human iPSCs are differentiated into cardiomyocytes (hiPSC-CMs) 
with monolayer-directed differentiation protocol. (A) At day 20 post differentiation, single hiPSC-
CMs are seeded onto hydrogel-based micropatterned surface and cultured until experimental day 60, 
75 and 90. (B) Left: fabrication of micropatterned hydrogel with PDMS mold and PEG-DA hydrogel 
synthesis by soft lithography (scale bars equal to 10 and 60 µm respectively). hiPSC-CM preferential 
spreading along thepattern direction (indicated by yellow line). (C) Simultaneous recording of action 
potential and calcium transients using Fluovolt (Ex/em 522/535 nm) and Cal630 (Ex/Em 608/626 nm), 
respectively. 
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Figure 1. Experimental procedure. Human iPSCs are differentiated into cardiomyocytes (hiPSC-CMs)
it l er- irecte differentiation protocol. (A) At day 20 post differentiation, single hiPSC-CMs
are seeded onto hydrogel-based micropatterned surface and cultured until experimental day 60, 75 and
90. (B) Left: fabrication of micropatterned hydrogel with PDMS mold and PEG-DA hydrogel synthesis
by soft lithography (scale bars equal to 10 and 60 µm respectively). hiPSC-CM preferential spreading
along thepattern direction (indicated by yellow line). (C) Simultaneous recording of action potential
and calcium transients using Fluovolt (Ex/em 522/535 nm) and Cal630 (Ex/Em 608/626 n ), respectively.
To validate the reproducibility of functional data from cells of a single cell line, we evaluated the
variability among different batches of the same cell line obtained from distinct differentiation runs
(p, indicates the passage in culture). CaT amplitude and RT50 values from 2 different cell batches
at d60 (Figure S1A,B, respectively) and d90 (Figure S1C,D, respectively) were compared, in order
to demonstrate that: (1) the inter-batches variability is comparable to the variability within each
individual batch, (2) the maturation of calcium transients over-time observed in each individual batch,
reflects that of the general combined population. Figure S1A,C show comparison of CaT amplitude
and decay (RT50, ms) among individual differentiations (from a single passage, p) versus the average
of total differentiations at day 60 and 90.
However, the increase of CaT amplitude is consistent for individual differentiations at d90
compared to d60. Similarly, distribution of RT50 values were more consistent within single batches at
all considered time points (Figure S1B,D).
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Figure 2. Dual recording of action potential and calcium transient in later-stages hiPSC-CMs. Single
hiPSC-CMs matured on hydrogel-based micropatterned surfaces were subjected to simultaneous
optical measurements of action potentials and calcium transients under electrical pacing (1 and 2 Hz) at
37 ◦C at and external [Ca2+] = 1.8 mM. (A) Superimposed action potential (AP) traces of day 75 (N = 2;
n = 186) vs. day 90 (N = 2; n = 119) recorded by FluoVolt. AP profile of hiPSC-CMs was recorded both
at 1 and 2 Hz to evaluate action potential duration (APD50, ms) and the response to frequency changes
at both day 75 and 90. (B) Superimposed normalized traces of calcium transients recorded by Cal630 at
day 60 (N = 3; n = 336), 75 (N = 5; n = 251) and 90 (N = 3; n = 165): average calcium transient (CaT)
rise (time to peak TTP, ms) and CaT decay (difference of 50% of CaT decay and TTP, RT50, ms) are
reported, during pacing at 1 and 2 Hz (C) Representative CaT profiles at day 60 and 90 and average CaT
amplitude (in arbitrary fluorescence units, A.U.) at day 60,75 and 90. (D) Representative simultaneous
recordings of action potential and intracellular calcium transient from adult ventricular cardiomyocytes,
elicited with short current pulses in current-clamp mode at 1 Hz. Average time to peak (Ca TTP) and
time from peak to 50% decay (Ca RT50) of Ca transients, and time from stimulus to 50% repolarization
(APD50) of action potentials at 1 Hz. Means ± SEM from 27 myocytes (nine control patients). Data are
reported as means ± SEM; one-way analysis of variance (ANOVA) with a Tukey post-hoc test with
statistical significance set at * p < 0.05 and ** p < 0.01; NS not significant. Supporting information given
in Table S2. N = number of differentiations; n = cells.
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The sarcoplasmic reticulum (SR) is the main store of calcium in cardiomyocytes. SR proteins, 
including RyR2, SERCA-2a and phospholamban (PLB) were shown to be expressed in hiPSC-
cardiomyocytes [19]. However, fewer reports have described their functional contribution at later-
stages hiPSC-CMs. A post rest potentiation protocol was applied to evaluate the maturation of 
cardiomyocyte inotropic reserve when cells are cultured in our conditions. hiPSC-CMs were paced 
at 2 Hz and, following a stimulation pause of 5 s, the amplitude of the first CaT after stimulation is 
resumed the pause was measured to evaluate the rest-mediated potentiation. This potentiation is 
related to prolonged SR refilling and enhanced RyR2 channel availability, because of the complete 
recovery from inactivation/adaptation of RyR channels during the longer rest period (Figure 4A). 
CaT amplitude after the rest pause displayed a modest potentiation over the amplitude before the 
pause at day 60. However, the amplitude of post-rest CaTs almost doubled at day 90, suggesting 
increased SR loading capacity during maturation (day 60 vs. 90, p < 0.01). To verify the contribution 
of SR calcium content, we evaluated caffeine-induced calcium transients (quick exposure to 10 µM 
Figure 3. Correlative an lysis of action potential and c lcium transient paramete s. Pea on co relation
coefficient (r2) stimated by line r regression (r d line) to correlate APD50 (ms) against CaT amplitude
(NS, not significant) and CaT duratio (RT50, ms, p < 0.05) of (A) day 90 hiPSC-CMs and (B) (human)
hAdult CMs from donor ventricular tissue (p < 0.05).
2.3. Sarcoplasmic R ticulum Contribution to Calcium Handling o Later-Stages hiPSC-Cardiomyocytes
The sarcoplasmic reticulum (SR) is the main store of calcium in cardiomyocytes. SR
proteins, including RyR2, SERCA-2a and phospholamban (PLB) were shown to be expressed in
hiPSC-cardiomyocytes [19]. However, fewer reports have described their functional contribution at
later-stages hiPSC-CMs. A post rest potentiation protocol was applied to evaluate the maturation of
cardiomyocyte inotropic reserve when cells are cultured in our conditions. hiPSC-CMs were paced
at 2 Hz and, following a stimulation pause of 5 s, the amplitude of the first CaT after stimulation is
resumed the pause was measured to evaluate the rest-mediated potentiation. This potentiation is
related to prolonged SR refilling and enhanced RyR2 channel availability, because of the complete
recovery from inactivation/adaptation of RyR channels during the longer rest period (Figure 4A). CaT
amplitude after the rest pause displayed a modest potentiation over the amplitude before the pause at
day 60. However, the amplitude of post-rest CaTs almost doubled at day 90, suggesting increased
SR loading capacity during maturation (day 60 vs. 90, p < 0.01). To verify the contribution of SR
calcium content, we evaluated caffeine-induced calcium transients (quick exposure to 10 µM caffeine)
after a pacing train of 2 Hz. The a plitude of caffeine-induced CaT at d60 was doubled compared to
corresponding steady state calci m transients at 2 Hz pacing.
We then measured the amplitude of caffeine-in uced CaT estimated as th ratio of caffeine-CaT
amplitude (CaTA CAFF) and the CaT amplitude before caffeine exposure (CaTA 2Hz). In day
60-hiPSC-CMs the relative caffeine-induced CaT amplitude was higher compared to that of hAdult-CMs
(Figure 4B). These results indicate a significant contribution of calcium release from the SR to the
amplitude of calcium transients starting from day 60 and suggest that the enhanced SR calcium load
is the main determinant of the progressive increase of CaT amplitude of hiPSC-CMs from day 60 to
day 90.
In addition, the time constant of the decay of caffeine-induced transients (τ, s−1) is an indirect
measurement of calcium removal operated by the sodium calcium exchanger (NCX) during exposure
to caffeine. The time constant of caffeine transient decay was about 25% slower compared to that
calculated in hAdult-CMs. This supports the idea that after maturation in our conditions, d60
hiPSC-CM feature calcium removal pathways (e.g., NCX) with a rate near to but still not the same of
hAdult-CMs. Moreover, simultaneous recording of AP and calcium dynamics was employed to assess
the potentiation of CaT amplitude and the prolongation of CaT decay after the pause, as well as the
impact of prolonged pauses on the APD50 of the first beat after the resting period (Figure 4C). Both
RT50 of CaT and APD50 of post rest beats were prolonged when compared with steady state beats,
at every maturation time point.
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Figure 4. Sarcoplasmic reticulum contribution during hiPSC-CM maturation. Sarcoplasmic reticulum
(SR) contribution in calcium handling maturation was tested by a post rest potentiation protocol and
caffeine-induced CaTs elicited in hiPSC-CMs at multiple maturation time-points. (A) The post-rest
potentiation of CaT amplitude was estimated after a resting pause of 5 s, inserted in a regular train
of stimulation at 2 Hz. The potentiation is expressed as the % increase of CaT amplitude at the first
post-rest beat from that of the last calcium transient before the pause (%). Post rest potentiation is
estimated at day 60 and day 90. (B) Caffeine-induced CaTs (quick exposure to 10 µM caffeine) after a
series of 2 Hz paced CaTs. Average of caffeine transient amplitude was normalized by the amplitude of
steady-state calcium transients at 2 Hz prior to caffeine exposure (N = 2; n = 83). Caffeine transient CaT
amplitude (CaTA CAFF/CaTA 2Hz ratio) and decay (τ, s−1) of hiPSC-CMs were calculated and compared
with caffeine-CaT recorded in hAdult-CMs (N = 5; n = 14). (C) Simultaneously recorded APs and CaTs
during the pause protocol. (D) APs and CaTs from the same cells were compared to show Pearson’s
correlation (r2) between post rest AP duration (APD50, ms) and post rest CaT decay (RT50, ms, p < 0.05).
(E) Variations of post rest APD50 and (F) post rest RT50 were measured both at day 75 (AP: N = 2,
n = 119; CaT: N = 5, n = 2 1) and day 90 (AP: N = 2, n = 119; CaT: N = 3, = 165). One-way analysis of
variance (ANOVA) with a Tukey post-hoc test with statistical significance set at * p < 0.05 and ** p < 0.01;
NS not significant. Supporting information is reported in Table S2. N = number of differentiations or
patients; n = cells.
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Additionally, the duration of post-rest APs and CaTs in the different cells were directly correlated.
However, compared to earlier phases (d60), both post-rest APD50 and RT50 became shorter at d90
(Figure 4E,F, respectively), likely suggesting improved cytosolic calcium extrusion via NCX and/or
reuptake by SERCA.
2.4. Ca-Handling Response to Inotropic Intervention of Later-Stages hiPSC-Cardiomyocytes
Another key aspect we explored during hiPSC-CM maturation is the response to inotropic
agents. We tested the effect of 1 µM isoproterenol (ISO) and forskolin (FSK) to mimic the β-adrenergic
pathway. Isoproterenol binds β-adrenergic receptor (βAR) type 1 and 2 in cardiac cells and activates
the cAMP-PKA phosphorylation pathway. Similarly, FSK stimulates adenylate cyclase rising cAMP
levels to activate PKA. We exposed day 90-hiPSC-CMs to ISO or FSK after basal recording of APs
and CaTs to evaluate the relative inotropic and lusitropic effect (%) during regular stimulation. ISO
reduced APD50 in hiPSC-CMs paced at 1 Hz (Figure 5A).
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Figure 5. Positive β-adrenergic response of later stage hiPSC-CMs. Day 90 hiPSC-CMs were exposed to
isoproterenol (ISO, 1µM) and forskolin (FSK, 1µM). (A) Representative traces of hiPSC-CM AP recorded
before and under ISO stimulation. APD50 reduction under ISO was 12± 4%, p> 0.05. (B) Representative
traces of ISO effect on the APD50 of human adult cardiomyocytes (15 ± 3%, p < 0.05)(hAdult-CMs:
N = 5 patients, n = 12 cells). (C,D) Relative positive inotropic and lusitropic effects of both ISO and
FSK (%) in later stages hiPSC-CMs (ISO: N = 2, n = 7; FSK: N = 2, n = 21). Supporting information is
reported in Table S2.
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Similarly, APD50 reduction under ISO was observed in hAdult-CMs (Figure 5B). Accordingly,
RT50 of CaT was faster under both ISO and FSK exposure in hiPSC-CMs (Figure 5C), consistent
with typical βAR-mediated positive lusitropic effect. In addition, both ISO and FSK enhanced CaT
amplitude, indicating positive inotropic response (Figure 5D).
2.5. Membrane Potential and Spontaneous Action Potential of Earlier-Stage hiPSC-CMs
To support and validate optical AP measurements, the patch clamp technique was employed to
measure APs in early-stage hiPSC-CMs (day 20, 30, 60 p.d.), during stimulation with short current
pulses in the current-clamp configuration at different frequencies (0.5–1–2 Hz, Figure 6A). Figure 6B
shows that, compared to the earliest-stage (d20), hiPSC-CMs at later stages of maturation showed
progressively more negative resting membrane potentials (RMP, mV), larger AP amplitude (mV) and
prolongation of AP duration (APD50). Moreover, hiPSC-CMs at later-stages (d60) showed a trend
towards rate-adaptation of AP duration. However, a clear adult-like rate-dependency of APD develops
only at day 90, as shown in Figure 2A. Notably, spontaneous beating frequency, measured in patched
cells without stimulation, showed a progressive reduction from day 20 to 60 p.d. (Figure 6C). Of note,
mature hiPSC-CMs (from day 60) do not show a significant spontaneous beating activity.
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Figure 6. Action potential recording by patch clamp in earlier stages hiPSC-CMs. Earlier-stages
hiPSC-CMs duri g patch clamp, elicited with s ort curre t pulses in current-clamp mode at day 20, 30
and 60. (A) Represent tive traces at 0.5, 1 and 2 Hz stimulation rates. (B) Average of resting membrane
potential (mV), AP amplitude (mV), time from stimulus to 50% repolarization (APD50, ms) at 1 Hz and
to 90% of repolarization (APD90, ms) with frequency variation. (C) Spontaneous beating frequency
of action potential from day 20 to day 60. Data are reported as means ± SEM; One-way analysis of
variance (ANOVA) with a Tukey post-hoc test with statistical significance set at * p < 0.05 and ** p < 0.01;
NS not significant.
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3. Discussion
Twelve years after the first study describing the generation of iPSCs [1], there are high expectations
related to the use of human hiPSC-CMs from patients or donors as disease models for studying the
pathophysiology of cardiac diseases or for testing novel targeted therapies. However, hiPSC-CMs
must be extensively validated against native functional human myocardium, in order to define current
and potential applications of this widely used technology. Unfortunately, an accurate comparison of
the functional features of hiPSC-CMs and native human ventricular cardiomyocytes is still lacking.
In this work, we presented a systematic functional characterization of action potential (AP) and calcium
handling maturation using a dual optical method at specific time points in later stages hiPSC-CMs
(day 60, 75 and 90 post differentiation) cultured on biomimetic substrates with micropatterned
topography and physiological stiffness in the range of kPa. Functional data from hiPSC-CMs
are compared with those obtained in freshly isolated cardiomyocytes from surgical ventricular
samples of non-failing non-hypertrophic patients, collected using standard electrophysiological and
fluorescence techniques.
We performed simultaneous recordings of action potential and calcium transients with fluorescent
indicators at single cell level, to assess the key regulatory mechanisms of cardiac contraction. Thanks
to the use of a fast high-sensitivity and high-resolution camera, our methods allows high throughput
screenings of multiple cells in simultaneous, increasing the capability of assessing the variability of
functional data among different cells and different runs of differentiation. With our approach, we were
able to collect data from hundreds of single hiPSC-CMs in each condition and at each differentiation
step, eliminating biases related to selection and small sample size.
The voltage-sensitive dye Fluovolt has been previously shown to exhibit much higher signal
fidelity to traditional voltage-clamp recordings, as compared to other commonly used voltage-sensitive
dyes, such as ANNEP dyes [20]. As reported before, the amplitude of voltage signals recorded with
optical methods is influenced by cell membrane surface area and by the degree of dye loading, hence,
this parameter can be used only to assess relative variations of the same cell. Contrarily, the duration
of action potentials recorded with optical methods is not affected by cell density, membrane extension
or dye concentration [21]. In our hands, the duration of APs recorded from individual hiPSC-CMs
using the patch-clamp technique (earlier-stages) and Fluovolt approach (later-stages) were consistently
prolonged at any progressive time point. Moreover, the duration of APs recorded with Fluovolt
in hiPSC-CMs at 90 days was similar to that recorded in human adult ventricular cardiomyocytes
(hAdult-CMs) recorded using traditional voltage-clamp.
Previous findings on long-term cultured hiPSC-CMs have revealed changes of ion current density
and properties during cell maturation protocols with prolonged culture time [22]. After long-term
maturation on micropatterned hydrogels, hiPSC-CMs showed a prolongation of action potentials,
likely associated with a larger contribution of ICaL during the plateau phase, which prevails over
the increase of repolarizing outward potassium currents (IKr and Ito1), as previously described [23].
Moreover, the more negative resting membrane potential recorded by patch clamp after day 60 implies
an increase of ion currents that contribute to the diastolic potential (in particular IK1). The increase of
IK1 may also account for the decrease of spontaneous beating rate at 60 days p.d. and the consequent
increased response to external electrical pacing (field stimulation) and frequency changes. Other
possible contributors to the acquisition of this physiological behavior during hiPSC-CM maturation
are the decrease of funny current (If) and the increase of the delayed rectifier potassium currents
(IKs + IKr) [24]. Many ion currents (e.g., Ito1) undergo developmental changes, similar to those occurring
during the fetal cardiac development [22]. For this reason, the AP profile of early hiPSC-CMs maintains
some of the features of fetal cardiomyocytes. However, at day 90 the average AP duration and calcium
transients (CaT) duration measured in hiPSC-CMs more closely recapitulates the AP profile and CaT
kinetics of ventricular hAdult-CMs. In line with hAdult-CMs, AP duration was correlated with CaT
duration in hiPSC-CMs. On the other side, acceleration of CaT duration and adaptivness of CaT kinetics
and amplitude to frequency changes at later-stages are likely attributable to increase of SERCA/PLB
Int. J. Mol. Sci. 2019, 20, 3799 11 of 17
function, associated with the development of sarcoplasmic reticulum. Of note, the duration of CaT
decay in hiPSC-CMs was in the same range of that measured in hAdult-CMs. The presence of a more
mature SERCA function is also supported by observation of the caffeine transient decay rate (τ) in
hiPSC-CMs, which is near but still not the same compared with hAdult-CMs, suggesting improved
NCX function. Not least, we found positive lusitropic effect under β-adrenergic stimulation (ISO and
FSK), which entails amplified SERCA contribution (mediated by PLB phosphorylation), paralleled by
PKA-induced reduction of APD (IKs phosphorylation) under adrenergic stimulation. Similarly, CaT
rise (time to peak) was in the same range of hAdult-CMs [11].
Sarcoplasmic reticulum (SR) contribution was assessed both by applying stimulation pauses
and by estimating SR Ca2+load from measurements of caffeine-induced CaT amplitude. Greater
SR contribution appeared as the major contributor to the increased CaT amplitude and post rest
potentiation during hiPSC-CM maturation. In our conditions, both post rest CaTs and post-rest APs
were prolonged as compared with steady state beats. The prolongation of the post rest CaT decay
and APD declined in later stages of maturation, supporting the idea of increased role of SERCA
and NCX function contributing to calcium removal. Moreover, a more rapid calcium-dependent
inactivation of ICa-L in later stages may account for shorter APD50 after rest. In native cardiomyocytes,
a calcium/calmodulin (CaM) dependent inactivation (CDI) of ICa-L tunes the open probability of this
channel [25]. Thereby, later-stages hiPSC-CMs may have increased CaM tethering to the channel
C-terminus altering the interaction of CaM with the calcium channel C-terminus accelerating the
inactivation. After the resting pause, with larger Ca releases stronger CDI may limit integrated ICa
influx, shortening the APD and further limiting Ca entry and the earlier repolarization, which can favor
additional Ca extrusion via NCX [26]. On the other side, faster calcium transient decay after rest may
likewise suggest reduced myofibril calcium buffering during the CaT decay phase (faster thin filament
de-activation) [27], a likely consequence of the developmental shift from the slow skeletal (fetal) to
the cardiac (adult) troponin complex [7,28,29], which can contribute to SR-calcium pump via SERCA.
Finally, we report hiPSC-CMs showing a high rate of positive inotropic and lusitropic responses in
response to neurohormonal agonists. Previous observations provided evidence of the progressively
increased expression of β1, β2 and β3 adrenergic receptors (ARs) over a period of 90 days in culture,
showing thatβ2-ARs are the most prominent source of cAMP/PKA signaling and target of isoproterenol
in hiPSC-CMs [30]. We confirmed the presence of a working downstream pathway of adrenergic
signalling both via direct AR activation (isoproterenol) and by directly increasing intracellular cAMP
levels (FSK). Major targets of PKA-mediated phosphorylation involved in calcium dynamics include
ICa-L channels (inotropic), RyR2 channels (inotropic and chronotropic), PLB (inotropic and lusitropic),
cardiac Troponin I (cTnI) (lusitropic) and IKs (AP shortening, lusitropic). This provides evidence of an
independent maturation of the neurohormonal response of hiPSC-CMs in the absence of a sympathetic
system and of actual nerve terminations.
4. Materials and Methods
4.1. Human Adult Cardiomyocytes from Patient Tissue
The study follows the principles of WMA Declaration of Helsinki for medical research involving
human subjects. The experimental protocols were approved by the ethical committee of Careggi
University-Hospital of Florence (2006/0024713, renewed May 2009; 2013/0035305). The control cohort
comprised 10 patients aged <65 years undergoing heart surgery for aortic stenosis or regurgitation
and who required a septal myectomy operation due to the presence of a bulging septum causing
symptomatic obstruction. All patients had septal thickness <14 mm and preserved left ventricular
systolic function (ejection fraction > 55%). Clinical data are found in Supporting Information Table S1.
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4.2. Tissue Processing and Cell Isolation
Surgical septal specimens from patients (hAdult-CMs) were washed with standard cardioplegic
solution and processed within 30 min from excision. Ventricular tissue was minced and subjected to
enzymatic dissociation to obtain viable single myocytes, as previously described [13,31]
4.3. HiPSC Cardiac Differentiation and Single Cell Maturation
The isolation of the human cells and the subsequent reprogramming into iPSC lines was performed
in conformation with the Declaration of Helsinki. Urine-derived cells from a healthy male donor
into hiPSC lines (UC3-4 A1) using a lentiviral vector carrying Oct3/4, Sox2, Klf4 and c-Myc as
previously described [32]. For cardiac differentiation we applied a monolayer directed differentiation
protocol onto a Matrigel matrix (Matrigel® hESC-Qualified Matrix, Corning®, New York, NY, USA)
using the cardiac PSC Cardiomyocyte Differentiation Kit (Life Technologies, Thermo Fisher scientific,
Carlsbad, CA, USA) following the manufacturer’s instructions as previously described [17]. Briefly,
hiPSCs were maintained under feeder-free conditions in mTeSR medium (Stem Cell Technolgies,
Vancouver, Canada) on a Corning® Matrigel matrix and regularly passaged every 4–5 days. For cardiac
differentiation, hiPSC colonies with 70–80% confluency were chemically dissociated using 1× Tryple
(Life Technologies, Thermo Fisher scientific, Carlsbad, CA, USA), suspended into mTeSR with 5µM of
ROCK inhibitor (Y27632) and seeded as single cells onto Matrigel-coated wells of a 24 wells plate at a
cell density of 40,000 cell/well (24-well plate). At 70% of confluency (2–3 days) the medium is changed
to Cardiomyocyte Differentiation Medium A (referred as day 0) to start cardiac induction. Medium
A is replaced after two days with Medium B and following other 2 days with Medium C for final
differentiation. hiPSC are fed every other day with Medium C until spontaneously beating monolayers
appear (day 8–10). At day 12 and for further hiPSC-cardiomyocyte (hiPSC-CM) maturation, Medium
C is replaced with RPMI plus B27 supplement (Life Technologies, Thermo Fisher scientific, Carlsbad,
CA, USA). On day 20 post differentiation, single cells are obtained from beating monolayers for further
cardiac maturation on hydrogel-based micropatterned surfaces.
4.4. Maturation on PEG-DA Hydrogel with Micropatterned Topography
Single hiPSC-CMs are obtained from beating monolayers with enzymatic dissociation (10 min
at 37 ◦C) with Tryple (Life Technologies, Thermo Fisher scientific, Carlsbad, CA, USA). Plating
media is composed by RPMI/B27 and 10 µM ROCK inhibitor. Cells are seeded at the density of
20,000 cells/cm2 onto biomimetic substrates and fed every other day until experimental days. Dual
recording experiments of long-term cultured hiPSC-CMs were performed at day 60, 75 and 90 p.d.
For patch clamp recordings, hiPSC-CMs were used at day 15, 30 and 60 from cardiac induction.
4.5. Fabrication of PEG-DA Hydrogel Substrate with Micropatterned Topography
Micropatterned substrates were prepared by soft lithographic technique. A master sample was
replicated by a PDMS (polydimethylsiloxane) mold that is used as template for the pattern replication
(Figure S2).
Master fabrication—Master samples was obtained by laser writer lithography (µPG101 laser writer,
Heidelberg, city, state abbrev, country, 800 nm resolution) (Figure S1A,B). A commercial optical resist
(AZ 1505 Merck Performance Materials GmbH, Merck Group, Darmstadt, Germany) was spun over
2 cm × 2 cm Si wafers and exposed to a laser spot (λ= 375 nm) with beam intensity of 16 mW. The length
of the linear stripes was set to 1 cm, while their width and spacing were fixed to 0.6 µm and 1.4
µm respectively. After exposure process, the samples were developed for 30 s in a 1:1 solution of
AZ Developer (Merck Performance Materials GmbH, Merck Group, Darmstadt, Germany) in water,
and subsequently rinsed in deionized water for 120 s.
Glass slides treatment—Glasses to support the PEG patterns were silanized to prevent the peeling-off
of the hydrogel during the cell culture. First, glasses were washed with an alkaline piranha solution
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(water, aqueous ammonia and hydrogen peroxide 5:1:1 v/v) at 70 ◦C for 15 min. Then, the glass were
rinsed with water and the isopropyl alcohol and, after drying, they were immersed in a solution of
3-(trimethoxysilyl) propyl methacrylate) (MAPTMS, 0.064 mM in ethanol) for 1 h. At the end, glasses
were washed with isopropanol and dried.
Fabrication of PDMSmold—Monomeric PDMS mixture was prepared by mixing the two components
of a commercially available PDMS kit (Sylgard 184, Sigma-Aldrich, Merck Group, St. Louis, MI, USA)
in a 10:1 w/w ratio (base and curing agent) and then casted on the silicon master. After curing at 100 ◦C
for 30 min, the crosslinked PDMS mold was peeled off by the master (Figure S2C).
PEG-DA pattern printing—A small amount (~20 µL) of a solution of PEG-DA (250 Mn,
Sigma-Aldrich, Merck Group, St. Louis, MI, USA) and Irgacure 389 photoinitiator (1% w/w) was
dropped on a silanized glass slides and then, the PDMS mold was directly placed onto the surface.
Irradiation by UV light (λ = 385 nm)(M385CP1-C4, ThorLabs, Newton, NJ, USA) for 10 min allowed the
formation of the crosslinked PEG-DA network. PDMS mold was gently peeled off from the substrates
and used again after washing in water and methanol. Images of mold and micropatterned PEG-DA
hydrogels were obtained by scanning electron microscopy (SEM) (Figure S2C).
4.6. Dual Recording of Action Potential and Calcium Transient
For dual recordings of APs and CaTs, hiPSC-CMs were loaded with 2 µL/mL Fluovolt (Thermo
Fisher, Waltham, MA, USA), 2 µL/ml of Cal630 (AAT Bioquest, Sunnyvale, CA, USA) and 5 µL
of Power Load™ concentrate (Thermo Fisher, Waltham, MA, USA) for 30 min at 37 ◦C and then
washed with pre-warmed culture media before placing the cover slide into the experimental chamber.
The experimental chamber features platinum electrodes for electrical field stimulation, connected to
a stimulator (DigiTimer, Welwyn Garden City, UK) delivering short (3 ms) voltage pulses. During
measurements, cells were continuously perfused with heated Tyrode buffer to keep the temperature
stable at 37 ± 1 ◦C. For fluorescence studies, cells were simultaneously illuminated by LED light at two
different wavelengths, blue (488 nm) for excitation of Fluovolt and yellow (580 nm) for Cal630 dye
excitation, using a multi-led system (Lumencor SPECTRA X, Beaverton, OR, USA). A dual-wavelenght
band-pass filter cube (Semrock, IDEX, Lake Forest, IL, USA) was used to allow fluorescence light from
the two dyes to be collected by a single camera (Photometrics Prime sCMOS, Teledyne, Tucson, AZ,
USA): in particular, the filter allowed green light (515–545 nm, emission of Fluovolt) and red light
(615–655 nm, emission of Cal630) to be collected. In order to separate the two emission wavelengths,
we used an OptoSplit II light splitter (Cairn Research Ltd, Kent, UK) that was able to separate the two
spectral components of the fluorescence image and focus them simultaneously on the upper and lower
half of the camera chip. MetaMorph software (Molecular Devices, San Jose, CA, USA) was used to
collect and analyze fluorescence images. The camera collected images at an average rate of 90 frames
per second. In each selected microscope view field, a number of single hiPSC-CMs were selected and
chosen as regions of interest. The background-corrected average fluorescence values from the pixels
in each selected region of interest (myocyte) were recorded at each of the two wavelengths under
different stimulation conditions for 5 to 10 s in each condition. For the analysis of action potential or
calcium transient kinetics during steady-state stimulation, the average of 5–10 subsequent AP or CaT
traces was calculated to reduce noise. Pearson’s correlation coefficient (r2) was calculated from the
linear fitting of values distribution recorded from individual cells.
4.7. Perforated Patch Clamp and Calcium Transient Recording
In cardiomyocytes freshly isolated from patient ventricular tissue, we simultaneously measured
membrane potential and calcium transients using perforated patch whole-cell current-clamp combined
with fluorescence recordings after loading with the Ca2+-sensitive fluorescent dye Fluoforte (Enzo
Life Sciences, Farmingdale, NY, USA), as previously described [31]: fluorescence was measured at
515 ± 10 nm during excitation at 490 ± 8 nm. For hiPSC-CMs, we used whole-cell current clamp
to measure APs; the pipette solution contained (in × 10−3 M) 115 K methanesulfonate, 25 KCl,
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10 (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES), 3 MgCl2, and cells were perfused
with Tyrode buffer containing 1.8 × 10−3 M CaCl2. APs were elicited with short depolarizing current
pulses (< 3 ms) at 1 Hz frequency. Action potentials were analyzed for MDP (mV), amplitude (mV),
and action potential duration (ADP50 and APD90, ms) using the Clampfit 10.7 software (Molecular
Devices, San Jose, CA, USA).
4.8. Statistics
All data are reported as mean ± SEM and were compared using a one-way or two-way analysis
of variance (ANOVA). Tukey post hoc test with statistical significance set at * p < 0.05 and ** p< 0.01
were applied for differences in means between groups/conditions. The interquartile range test
was performed for data distribution and selection. For each analysis, n represented number of
cardiomyocytes and N the total number of cell differentiation runs from individual hiPSC passages
(p) or individual patients. For this work healthy cell line had N = 3–5. The number of individual
experiments (individual coverslides) for each assessment was at least 2 from different differentiation
runs. Supporting information of results is reported in Table S2.
5. Conclusions
This is a pilot study on a control hiPSC-CM line that we have widely described before in many
aspects [7,9,32]. Although the work is restricted to a single cell line, we aimed to present a simple
biomimetic culture approach and a technique for simultaneous comparison of functional output at
different maturation time points. In addition, future studies may consider real longitudinal evaluations
using genetically-encoded fluorescent voltage or calcium indicators (GEVI or GECI, respectively) to
track the functional performance from the same cell at different stages of maturation. The advantage of
comparing hiPSC-CMs with adult cardiomyocytes from control patients provided a stronger evidence
of the maturation of E-C coupling function towards adult-like ventricular features. However, despite
the greater degree of organization and adult-like cell structure, mature hiPSC-CMs still display
protein expression and contractile properties that are typically found in the fetal myocardium [7].
For this reason, future directions must provide evidence of how can we overcome the developmental
plateau of hiPSC-cardiomyocytes. Functional improvements may come from the alteration of the
extracellular milieu towards more physiological conditions or improving multicellular hiPSC-CM
tissue models. Finally, for further validation of hiPSC-CM models for personalized-medicine or
inherited cardiomyopathy studies, novel insights must be corroborated with clinical information or,
ideally, with experiments from cardiomyocytes isolated from the cardiac tissue of the same patient,
obtained through biopsies or surgery.
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Abbreviations
hiPSC Human induced pluripotent stem cell
hAdult- Human adult
AP Action potential
APD Action potential duration
CaT Calcium transient
CM Cardiomyocyte
CaM Calmodulin
CDI Calcium/CaM dependent inactivation
TTP Time to peak
RT50 Time to 50% relaxation
NCX Sodium calcium exchanger
RyR2 Ryanodine receptors 2
SERCA Sarco-Endoplasmic Reticulum Calcium ATPase-2A
PLN Phospholamban
PKA Protein kinase A
cAMP Cyclic adenosine monophosphate
ISO Isoproterenol
FSK Forskolin
ICaL Inward calcium current
Ito1 Transient outward potassium current
IKr Inward-rectifier potassium current
IKs Slow delayed rectifier potassium current
If Funny current
p.d. Post differentiation
p Passage
r2 Pearson’s correlation coefficient
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